The program includes access to FDA-approved Wegovy (semaglutide) and FDA-approved Zepbound (tirzepatide), both GLP-1 receptor agonists
Patients should report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Planning Your Transition Off Tirzepatide for Conception The ideal approach is to work with your prescribing physician to establish a conception timeline and create a transition plan at least 6-12 months before attempting pregnancy
KEY DETAILS Program starts July 1, 2026 Flat $50 patient copay No deductible Only 28- or 30-day fills A new PA is required when switching medications Prescribers do not need to be enrolled in Medicare, but cannot be on the CMS Preclusion List Please share this with prescribers, pharmacists, nurses, medical assistants, and prior authorization teams
About us Why choose SoCal Plastic Surgeons for your weight loss treatment
I see Amy for my yearly check-ups and she is very thorough and answers all my questions